The SURMOUNT-4 trial showed that discontinuing tirzepatide after 36 weeks of treatment led to significant weight regain, with participants regaining about half of the weight they had lost
DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P (2011) Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes
July 17, 2025 Exploring Hair Loss Solutions Hair loss affects millions of people, regardless of sex , and often becomes more noticeable with age, hormonal changes, or stress
Jensterle M, Herman R, Janez A (2022) Therapeutic Potential of Glucagon-like peptide-1 Agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives
Dermatologist-founded Rodan and Fields further reinforces interest in hybrid complexion products that combine cosmetic performance with skincare benefits